Issue 3/2017
Content (24 Articles)
Clearing the fog: a review of the effects of dietary omega-3 fatty acids and added sugars on chemotherapy-induced cognitive deficits
Tonya S. Orchard, Monica M. Gaudier-Diaz, Kellie R. Weinhold, A. Courtney DeVries
Aryl hydrocarbon receptor induced intratumoral aromatase in breast cancer
Ryoko Saito, Yasuhiro Miki, Shuko Hata, Takanori Ishida, Takashi Suzuki, Noriaki Ohuchi, Hironobu Sasano
Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status
Yul Ri Chung, Hyun Jeong Kim, Min Hye Jang, So Yeon Park
Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer
Michel van Gelder, Ariane Vanclée, Catharina H. M. J. van Elssen, Pierre Hupperets, Lotte Wieten, Gerard M. Bos
Estimating the OncotypeDX score: validation of an inexpensive estimation tool
Anne A. Eaton, Catherine E. Pesce, James O. Murphy, Michelle M. Stempel, Sujata M. Patil, Edi Brogi, Clifford A. Hudis, Mahmoud El-Tamer
Effects of exercise intervention in breast cancer patients: is mobile health (mHealth) with pedometer more effective than conventional program using brochure?
Kyeong Eun Uhm, Ji Sung Yoo, Seung Hyun Chung, Jong Doo Lee, Ilkyun Lee, Joong Il Kim, Se Kyung Lee, Seok Jin Nam, Yong Hyun Park, Ji Youl Lee, Ji Hye Hwang
Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer
Jason D. Robarge, Zereunesay Desta, Anne T. Nguyen, Lang Li, Daniel Hertz, James M. Rae, Daniel F. Hayes, Anna M. Storniolo, Vered Stearns, David A. Flockhart, Todd C. Skaar, N. Lynn Henry
Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients
J. Shiao, K. M. Thomas, A. S. Rahimi, R. Rao, Jingsheng Yan, Xian-Jin Xie, M. DaSilva, A. Spangler, M. Leitch, R. Wooldridge, A. Rivers, D. Farr, B. Haley, D. W. Nathan Kim
Efficacy and safety of low-dose capecitabine plus docetaxel versus single-agent docetaxel in patients with anthracycline-pretreated HER2-negative metastatic breast cancer: results from the randomized phase III JO21095 trial
Daigo Yamamoto, Nobuaki Sato, Yoshiaki Rai, Yutaka Yamamoto, Mitsue Saito, Hiroji Iwata, Norikazu Masuda, Shoji Oura, Junichiro Watanabe, Satoshi Hattori, Yoshimasa Matsuura, Katsumasa Kuroi
Does the TNM classification of solitary internal mammary lymph node metastases in breast cancer still apply?
V. Habraken, T. J. A. van Nijnatten, L. de Munck, M. Moossdorff, E. M. Heuts, M. B. I. Lobbes, M. L. Smidt
Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians
Foluso O. Ademuyiwa, Yu Tao, Jingqin Luo, Katherine Weilbaecher, Cynthia X. Ma
Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis
Song Yao, Yali Zhang, Li Tang, Janise M. Roh, Cecile A. Laurent, Chi-Chen Hong, Theresa Hahn, Joan C. Lo, Christine B. Ambrosone, Lawrence H. Kushi, Marilyn L. Kwan
Association between adjuvant chemotherapy and risk of acute kidney injury in elderly women diagnosed with early-stage breast cancer
Shuling Li, Jiannong Liu, Beth A. Virnig, Allan J. Collins
The impact of doctor–patient communication on patients’ perceptions of their risk of breast cancer recurrence
Nancy K. Janz, Yun Li, Brian J. Zikmund-Fisher, Reshma Jagsi, Allison W. Kurian, Lawrence C. An, M. Chandler McLeod, Kamaria L. Lee, Steven J. Katz, Sarah T. Hawley
Prognostic impact of metastatic pattern in stage IV breast cancer at initial diagnosis
Bernardo Amadeo Leone, Carlos Teodoro Vallejo, Alberto Omar Romero, Mario Raúl Machiavelli, Juan Eduardo Pérez, Julieta Leone, José Pablo Leone
Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed
Wendie D. den Brok, Caroline H. Speers, Lovedeep Gondara, Emily Baxter, Scott K. Tyldesley, Caroline A. Lohrisch
Recurrence risk perception and quality of life following treatment of breast cancer
Sarah T. Hawley, Nancy K. Janz, Kent A. Griffith, Reshma Jagsi, Christopher R. Friese, Allison W. Kurian, Ann S. Hamilton, Kevin C. Ward, Monica Morrow, Lauren P. Wallner, Steven J. Katz
An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome
A. H. M. de Vries Schultink, X. Alexi, E. van Werkhoven, L. Madlensky, L. Natarajan, S. W. Flatt, W. Zwart, S. C. Linn, B. A. Parker, A. H. B. Wu, J. P. Pierce, A. D. R. Huitema, J. H. Beijnen
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results
Mary Pritzlaff, Pia Summerour, Rachel McFarland, Shuwei Li, Patrick Reineke, Jill S. Dolinsky, David E. Goldgar, Hermela Shimelis, Fergus J. Couch, Elizabeth C. Chao, Holly LaDuca
The influence of 21-gene recurrence score assay on chemotherapy use in a population-based sample of breast cancer patients
Yun Li, Allison W. Kurian, Irina Bondarenko, Jeremy M. G. Taylor, Reshma Jagsi, Kevin C. Ward, Ann S. Hamilton, Steven J. Katz, Timothy P. Hofer
Almost 2% of Spanish breast cancer families are associated to germline pathogenic mutations in the ATM gene
A. Tavera-Tapia, L. Pérez-Cabornero, J. A. Macías, M. I. Ceballos, G. Roncador, M. de la Hoya, A. Barroso, V. Felipe-Ponce, R. Serrano-Blanch, C. Hinojo, M. D. Miramar-Gallart, M. Urioste, T. Caldés, S. Santillan-Garzón, J. Benitez, A. Osorio
MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration
Gloria Bertoli, Claudia Cava, Cecilia Diceglie, Cristina Martelli, Giampiero Rizzo, Francesca Piccotti, Luisa Ottobrini, Isabella Castiglioni
The effects of laterality in stage IV breast cancer patients at initial diagnosis; much work is needed!
Kadri Altundag
Breast cancer is a systemic disease rather than an anatomical process
Bernardo Amadeo Leone, Julieta Leone, José Pablo Leone